Literature DB >> 8149471

Nitrate, nitrite and volatile N-nitroso compounds in the urine of Schistosoma haematobium and Schistosoma mansoni infected patients.

M H Mostafa1, S Helmi, A F Badawi, A R Tricker, B Spiegelhalder, R Preussmann.   

Abstract

The present study presents, for the first time, the amounts of nitrate, nitrite and volatile N-nitroso compounds in saliva and urine samples of Schistosoma haematobium and Schistosoma mansoni infected patients. Mid-morning saliva and 24 h urine samples were collected from male patients infected with S.haematobium (n = 129 saliva and 79 urine samples) and S.mansoni (n = 64 saliva and 65 urine samples) and in a comparative control group of healthy individuals (n = 27) from the Nile Delta region of Egypt. Saliva samples were analyzed for the presence of nitrate and nitrite; while urine samples were analyzed for the presence of nitrate, nitrite and volatile N-nitroso compounds. In the control group, N-nitroso-dimethylamine (NDMA) was detected at concentrations (mean +/- SD) of 0.27 +/- 0.47 microgram/day. N-Nitrosopiperidine (NPIP; 0.6 microgram/day) and N-nitrosopyrrolidine (NPYR; 0.4 microgram/day) were also present in one sample. S.mansoni infected subjects showed significantly (P < 0.001) higher levels of 2.9 +/- 2.9 micrograms/day NDMA and a higher frequency of NPIP (in 40/65 samples; 0.4 +/- 0.3 microgram/day) and NPYR occurrence (in 59/65 samples; 0.9 +/- 0.9 microgram/day). Significant further increases in the excretion of volatile N-nitroso compounds were found in S.haematobium-infected patients with mean daily excretion of 19.2 +/- 21 micrograms/day NDMA (in all samples; P < 0.001), 1.6 +/- 2.3 micrograms/day NPIP (in 56/79 samples; P < 0.001) and 1.3 +/- 1.9 micrograms/day NPYR (in 58/79 samples; P < 0.1). The differences either in salivary nitrite/nitrate or in urinary nitrite between the three distinct groups were not significant. However, the urinary excretion of nitrate was elevated from 139 +/- 82 mg/day in the control group to 249 +/- 126 mg/day in S.mansoni infected patients (P < 0.001) and to 174 +/- 176 mg/day in S.haematobium infected subjects (P < 0.005 in comparison to S.mansoni infected group). These results suggest a possible role of N-nitroso compounds in the etiology of schistosome-associated bladder cancer and imply a partial participation of S.mansoni in the multistage process of urinary schistosomiasis-associated bladder carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8149471     DOI: 10.1093/carcin/15.4.619

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  8 in total

Review 1.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

2.  Head and neck cancer in a developing country: a population-based perspective across 8 years.

Authors:  Esra Attar; Subhojit Dey; Ahmad Hablas; Ibrahim A Seifeldin; Mohamed Ramadan; Laura S Rozek; Amr S Soliman
Journal:  Oral Oncol       Date:  2010-07-08       Impact factor: 5.337

Review 3.  Relationship between schistosomiasis and bladder cancer.

Authors:  M H Mostafa; S A Sheweita; P J O'Connor
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

4.  Mass spectrometric analysis of a cyclic 7,8-butanoguanine adduct of N-nitrosopyrrolidine: comparison to other N-nitrosopyrrolidine adducts in rat hepatic DNA.

Authors:  Ana Paula M Loureiro; Wenbing Zhang; Fekadu Kassie; Siyi Zhang; Peter W Villalta; Mingyao Wang; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2009-10       Impact factor: 3.739

5.  Identification of adducts formed in the reaction of alpha-acetoxy-N-nitrosopyrrolidine with deoxyribonucleosides and DNA.

Authors:  Mingyao Wang; Yanbin Lao; Guang Cheng; Yongli Shi; Peter W Villalta; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2007-03-30       Impact factor: 3.739

Review 6.  Parasites and malignancies, a review, with emphasis on digestive cancer induced by Cryptosporidium parvum (Alveolata: Apicomplexa).

Authors:  S Benamrouz; V Conseil; C Creusy; E Calderon; E Dei-Cas; G Certad
Journal:  Parasite       Date:  2012-02-01       Impact factor: 3.000

Review 7.  Understanding Urogenital Schistosomiasis-Related Bladder Cancer: An Update.

Authors:  Kenji Ishida; Michael H Hsieh
Journal:  Front Med (Lausanne)       Date:  2018-08-10

Review 8.  Impact of human schistosomiasis in sub-Saharan Africa.

Authors:  Abiola Fatimah Adenowo; Babatunji Emmanuel Oyinloye; Bolajoko Idiat Ogunyinka; Abidemi Paul Kappo
Journal:  Braz J Infect Dis       Date:  2015-01-27       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.